Product liability risks are a key concern for life sciences manufacturers: any product that interacts with the human body will have an impact on a patient's physiology; but at what point does an acceptable side-effect become an injury and so make a product defective in the eyes of the law?   In this episode Osborne Clarke's regulatory lawyer Peter Rudd-Clarke sets out pointers for life sciences manufacturers as they prepare for the introduction of the new EU Product Liability Directive and upcoming reform in the UK.